Coverage Inconsistent for Popular Weight-Loss Drugs

Supplies of high-demand obesity treatments are improving, but that doesn't mean it's easier to get them. Many employers and insurers are ...

Published on February 24, 2025

Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medicati...

Published on February 24, 2025

Rare Syndrome Linked to COVID Vaccine

Recent research points to a new side effect of the COVID-19 vaccination. A small study found that some people can develop a troubling con...

Published on February 24, 2025

© 2025 BETTER/SMARTER.ME, A division of the Institute for the Future of Human Potential
200 First St. SW Rochester, MN 55905 | 1-800-328-IFHP
IFHRP research has not been evaluated by the Food and Drug Administration or any government agency.
IFHRP research is not intended to diagnose, treat, cure, or prevent disease.

Newsroom 1-800-328-IFHP

Newsroom
1-800-328-IFHP